Subsequently the phosphorylation of Bcl-2 was increased in the BMP4-treated groups whereas cells in the Noggin-treated groups inhibited the Bcl-2 phosphorylation, indicating the JNK1/Bcl-2 signaling might be a crucial mechanism involved in BMP4-promoted HCC cells growth. This evidence concerns the gene MAPK8 and hepatocellular carcinoma.